Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1

Approximately 10% of amyotrophic lateral sclerosis (ALS) cases are familial (known as FALS) with an autosomal dominant inheritance pattern, and ~25% of FALS cases are caused by mutations in Cu/Zn superoxide dismutase (SOD1). There is convincing evidence that mutant SOD1 (mtSOD1) kills motor neurons...

Full description

Bibliographic Details
Main Authors: Ghanashyam D. Ghadge, John D. Pavlovic, Sujatha P. Koduvayur, Brian K. Kay, Raymond P. Roos
Format: Article
Language:English
Published: Elsevier 2013-08-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996113001216
_version_ 1818574392544722944
author Ghanashyam D. Ghadge
John D. Pavlovic
Sujatha P. Koduvayur
Brian K. Kay
Raymond P. Roos
author_facet Ghanashyam D. Ghadge
John D. Pavlovic
Sujatha P. Koduvayur
Brian K. Kay
Raymond P. Roos
author_sort Ghanashyam D. Ghadge
collection DOAJ
description Approximately 10% of amyotrophic lateral sclerosis (ALS) cases are familial (known as FALS) with an autosomal dominant inheritance pattern, and ~25% of FALS cases are caused by mutations in Cu/Zn superoxide dismutase (SOD1). There is convincing evidence that mutant SOD1 (mtSOD1) kills motor neurons (MNs) because of a gain-of-function toxicity, most likely related to aggregation of mtSOD1. A number of recent reports have suggested that antibodies can be used to treat mtSOD1-induced FALS. To follow up on the use of antibodies as potential therapeutics, we generated single chain fragments of variable region antibodies (scFvs) against SOD1, and then expressed them as ‘intrabodies’ within a motor neuron cell line. In the present study, we describe isolation of human scFvs that interfere with mtSOD1 in vitro aggregation and toxicity. These scFvs may have therapeutic potential in sporadic ALS, as well as FALS, given that sporadic ALS may also involve abnormalities in the SOD1 protein or activity.
first_indexed 2024-12-15T00:26:03Z
format Article
id doaj.art-baa71045168d47a78b070779a5f94cc1
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-15T00:26:03Z
publishDate 2013-08-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-baa71045168d47a78b070779a5f94cc12022-12-21T22:42:10ZengElsevierNeurobiology of Disease1095-953X2013-08-01567478Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1Ghanashyam D. Ghadge0John D. Pavlovic1Sujatha P. Koduvayur2Brian K. Kay3Raymond P. Roos4Department of Neurology, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC2030, Chicago, IL 60637, USADepartment of Biological Sciences, University of Illinois at Chicago, 900 S. Ashland Ave., Molecular Biology Research Building, Room 4318, (M/C 567), Chicago, IL 60607, USADepartment of Biological Sciences, University of Illinois at Chicago, 900 S. Ashland Ave., Molecular Biology Research Building, Room 4318, (M/C 567), Chicago, IL 60607, USADepartment of Biological Sciences, University of Illinois at Chicago, 900 S. Ashland Ave., Molecular Biology Research Building, Room 4318, (M/C 567), Chicago, IL 60607, USADepartment of Neurology, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC2030, Chicago, IL 60637, USA; Corresponding author at: Department of Neurology/MC2030, University of Chicago Medical Center, 5841 S. Maryland Ave., Chicago, IL 60637, USA. Fax: +1 773 834 9089.Approximately 10% of amyotrophic lateral sclerosis (ALS) cases are familial (known as FALS) with an autosomal dominant inheritance pattern, and ~25% of FALS cases are caused by mutations in Cu/Zn superoxide dismutase (SOD1). There is convincing evidence that mutant SOD1 (mtSOD1) kills motor neurons (MNs) because of a gain-of-function toxicity, most likely related to aggregation of mtSOD1. A number of recent reports have suggested that antibodies can be used to treat mtSOD1-induced FALS. To follow up on the use of antibodies as potential therapeutics, we generated single chain fragments of variable region antibodies (scFvs) against SOD1, and then expressed them as ‘intrabodies’ within a motor neuron cell line. In the present study, we describe isolation of human scFvs that interfere with mtSOD1 in vitro aggregation and toxicity. These scFvs may have therapeutic potential in sporadic ALS, as well as FALS, given that sporadic ALS may also involve abnormalities in the SOD1 protein or activity.http://www.sciencedirect.com/science/article/pii/S0969996113001216Familial amyotrophic lateral sclerosisMutant superoxide dismutase type 1Amyotrophic lateral sclerosisALSSingle chain fragments of variable region antibodiesscFvs
spellingShingle Ghanashyam D. Ghadge
John D. Pavlovic
Sujatha P. Koduvayur
Brian K. Kay
Raymond P. Roos
Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1
Neurobiology of Disease
Familial amyotrophic lateral sclerosis
Mutant superoxide dismutase type 1
Amyotrophic lateral sclerosis
ALS
Single chain fragments of variable region antibodies
scFvs
title Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1
title_full Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1
title_fullStr Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1
title_full_unstemmed Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1
title_short Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1
title_sort single chain variable fragment antibodies block aggregation and toxicity induced by familial als linked mutant forms of sod1
topic Familial amyotrophic lateral sclerosis
Mutant superoxide dismutase type 1
Amyotrophic lateral sclerosis
ALS
Single chain fragments of variable region antibodies
scFvs
url http://www.sciencedirect.com/science/article/pii/S0969996113001216
work_keys_str_mv AT ghanashyamdghadge singlechainvariablefragmentantibodiesblockaggregationandtoxicityinducedbyfamilialalslinkedmutantformsofsod1
AT johndpavlovic singlechainvariablefragmentantibodiesblockaggregationandtoxicityinducedbyfamilialalslinkedmutantformsofsod1
AT sujathapkoduvayur singlechainvariablefragmentantibodiesblockaggregationandtoxicityinducedbyfamilialalslinkedmutantformsofsod1
AT briankkay singlechainvariablefragmentantibodiesblockaggregationandtoxicityinducedbyfamilialalslinkedmutantformsofsod1
AT raymondproos singlechainvariablefragmentantibodiesblockaggregationandtoxicityinducedbyfamilialalslinkedmutantformsofsod1